---
title: "603262.SH (603262.SH) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/603262.SH/news.md"
symbol: "603262.SH"
name: "603262.SH"
parent: "https://longbridge.com/zh-HK/quote/603262.SH.md"
datetime: "2026-03-10T08:13:28.886Z"
locales:
  - [en](https://longbridge.com/en/quote/603262.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603262.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603262.SH/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/603262.SH/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/603262.SH/news.md)


# 603262.SH (603262.SH) — 相關新聞

### [TaiJing CKD anemia new drug Phase I clinical trial completes first case enrollment](https://longbridge.com/zh-HK/news/277613292.md)
*2026-03-03T11:36:12.000Z*
> TaiJing Biotechnology (4157) announced that its new drug ISM-4808 for anemia in chronic kidney disease (CKD) has complet

### [Intraday News - Biotechnology and medical stocks performed strongly, rising by 2.08%, with a total transaction amount of 5.31 billion](https://longbridge.com/zh-HK/news/276686117.md)
*2026-02-24T05:07:23.000Z*
> Taiwan's biotechnology and medical stocks performed strongly today, with the relevant index rising by 2.08% and a total 

### [Star Power's post-meter energy storage solution helps Xinxin Biotechnology Food save on electricity costs and earn profits](https://longbridge.com/zh-HK/news/274774479.md)
*2026-02-04T07:45:26.000Z*
> Star Power and Xinxin Biotechnology Food have signed a memorandum of cooperation, becoming corporate partners in the ETF

### [Xiangrong Biotechnology advances into Southeast Asia, obtaining cosmetic qualification certification for exosomes in the Philippines](https://longbridge.com/zh-HK/news/273214964.md)
*2026-01-21T10:30:46.000Z*
> Xiangrong Biotechnology (6794) announced that its exosome products have received cosmetic notification approval from the

### [TSI: Change of some fundraising projects, involving approximately 99.75 million, accounting for 20.76%](https://longbridge.com/zh-HK/news/272946031.md)
*2026-01-19T08:30:28.000Z*
> TSI announced that the net amount raised from the company's initial public offering of shares is RMB 479.8182 million. O

### [Fangzheng Securities: The fundamentals of the health products industry are steadily improving, and the value of sector allocation is becoming increasingly apparent](https://longbridge.com/zh-HK/news/269166212.md)
*2025-12-10T02:19:03.000Z*
> The research report from Founder Securities points out that the nutritional health products market maintains high prospe

### [TSI released its performance for the first three quarters, with a net profit attributable to the parent company of 117 million yuan, a year-on-year decrease of 14.72%](https://longbridge.com/zh-HK/news/263297266.md)
*2025-10-29T13:03:31.000Z*
> According to the Zhitong Finance APP, TSI disclosed its third-quarter report for 2025. The company achieved revenue of 7

### [Aging + sports trend creates opportunities, TSI Group enters the Shanghai market with patent barriers](https://longbridge.com/zh-HK/news/250343393.md)
*2025-07-28T05:51:19.000Z*
> TSI Group successfully listed on the Shanghai Stock Exchange, becoming the largest supplier of HMB raw materials globall

### [A-share IPOs: "Certainty" Amid Uncertainty](https://longbridge.com/zh-HK/news/250320541.md)
*2025-07-28T01:25:37.000Z*
> This year, the A-share market is full of uncertainty, but subscribing to new shares has become the only certain choice f

### [TSI Group listed on the Shanghai Stock Exchange: Annual revenue of 1 billion, net profit of 170 million, market value of 17.5 billion](https://longbridge.com/zh-HK/news/249704209.md)
*2025-07-23T05:41:36.000Z*
> TSI Group was listed on the Shanghai Stock Exchange today, with an issue price of 10.88 yuan, an opening price of 51 yua